Activation of the hedgehog pathway in chronic myelogeneous leukemia patients

por Long, Bing, Zhu, Huanling, Zhu, Cuixia, Liu, Ting, Meng, Wentong
Publicado 2011

Antiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors—a Study in Leu...

por Dai, Yang, Huang, Jingcao, Xiang, Bing, Zhu, Huanling, He, Chuan
Publicado 2018

Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes

por Qin, Yao, Zhang, Hang, Feng, Lin, Wei, Haichen, Wu, Yuling, Jiang, Chaoran, Xu, Zhihong, Zhu, Huanling, Liu, Ting
Publicado 2022

PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC...

por LI, Weiming, Xu, Na, Xu, Zhongyuan, Zhang, Yanli, LI, Junmin, Zhu, Huanling, Zheng, LI, Yan, Xiaojing, Du, Xin, Hu, Yu
Publicado 2023

Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China

por Yang, Yunfan, Zhang, Yanli, Jiang, Qian, Meng, Li, Li, Weiming, Liu, Bingcheng, Liu, Xiaoli, Zhou, Li, Liang, Rong, Zhu, Xiaojian, NaXu, Kuang, Pu, Lin, Ting, Zhu, Huanling
Publicado 2022

Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia

por Luo, Hongmei, Qin, Yu, Reu, Frederic, Ye, Sujuan, Dai, Yang, Huang, Jingcao, Wang, Fangfang, Zhang, Dan, Pan, Ling, Zhu, Huanling, Wu, Yu, Niu, Ting, Xiao, Zhijian, Zheng, Yuhuan, Liu, Ting
Publicado 2016

Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN ra...

por Cortes, Jorge E., Jiang, Qian, Wang, Jianxiang, Weng, Jianyu, Zhu, Huanling, Liu, Xiaoli, Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald, Savona, Michael, Martin-Regueira, Patricia, Sy, Oumar, Gurnani, Renuka, Saglio, Giuseppe
Publicado 2020

Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services

por Bao, Mei, Yang, Sen, Gale, Robert Peter, Zhang, Yanli, Liu, Xiaoli, Zhu, Huanling, Liang, Rong, Liu, Bingcheng, Zhou, Li, Li, Zongru, Dou, Xuelin, Shi, Dayu, Wang, Tao, Meng, Li, Li, Weiming, Jiang, Qian
Publicado 2021

Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma

por Zhang, Li, Pan, Ling, Xiang, Bing, Zhu, Huanling, Wu, Yu, Chen, Meng, Guan, Pujun, Zou, Xingli, Valencia, C Alexander, Dong, Biao, Li, Jianjun, Xie, Liping, Ma, Hongbing, Wang, Fangfang, Dong, Tian, Shuai, Xiao, Niu, Ting, Liu, Ting
Publicado 2016

P1021: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE INTOLERANT TO RUXOLITINIB: AN OPEN-LABEL, SINGLE-ARM PHASE 2B STUDY

por Zhang, Yi, Zhou, Hu, Xiao, Zhijian, Duan, Minghui, Gao, Sujun, He, Guangsheng, Jing, Hongmei, LI, Junmin, MA, Liangming, Zhu, Huanling, Chang, Chunkang, Du, Xin, Hong, Mei, LI, Xin, Liu, Qingchi, Wang, Wei, Na, Xu, Yang, Haiping, Zhao, Qingwei, Jin, Jie
Publicado 2023

PB1968: IMPACTS ON OUTCOMES AND A PREDICTIVE MODEL OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING INITIAL NILOTINIB-THERAPY

por LI, Ziyu, Jiang, Qian, Zhang, Xiaoshuai, Zhang, Yanli, Xu, Na, Zhu, Huanling, Lin, Hai, LI, Weiming, Du, Xin, Liang, Rong, LI, Fei, Chen, Chunyan, Liu, Bingcheng, Wang, Xiaodong, Yang, Lijie, Liu, Zhenfang, Pang, Liping, Liu, Zhuogang, Sun, Xiuli, Bai, Yanliang, Meng, LI, Chen, Suning
Publicado 2023

Quality‐of‐life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia

por Chen, Yilin, Xu, Na, Yang, Yunfan, Liu, Zhenfang, Xue, Mengxing, Meng, Li, He, Qun, Chen, Chunyan, Zeng, Qingshu, Zhu, Huanling, Du, Xin, Zou, Jing, He, Wenjun, Guo, Jingming, Chen, Suning, Yuan, Guolin, Wu, Hui, Hong, Mei, Cheng, Fanjun, Liu, Bingcheng, Zhang, Yanli, Li, Weiming
Publicado 2023

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter p...

por Jiang, Qian, Li, Zongru, Qin, Yazhen, Li, Weiming, Xu, Na, Liu, Bingcheng, Zhang, Yanli, Meng, Li, Zhu, Huanling, Du, Xin, Chen, Suning, Liang, Yang, Hu, Yu, Liu, Xiaoli, Song, Yongping, Men, Lichuang, Chen, Zi, Niu, Qian, Wang, Hengbang, Lu, Ming, Yang, Dajun, Zhai, Yifan, Huang, Xiaojun
Publicado 2022

Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, m...

por Jiang, Qian, Li, Zongru, Qin, Yazhen, Li, Weiming, Xu, Na, Liu, Bingcheng, Zhang, Yanli, Meng, Li, Zhu, Huanling, Du, Xin, Chen, Suning, Liang, Yang, Hu, Yu, Liu, Xiaoli, Song, Yongping, Men, Lichuang, Chen, Zi, Niu, Qian, Wang, Hengbang, Lu, Ming, Yang, Dajun, Zhai, Yifan, Huang, Xiaojun
Publicado 2022

Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, m...

por Jiang, Qian, Li, Zongru, Qin, Yazhen, Li, Weiming, Xu, Na, Liu, Bingcheng, Zhang, Yanli, Meng, Li, Zhu, Huanling, Du, Xin, Chen, Suning, Liang, Yang, Hu, Yu, Liu, Xiaoli, Song, Yongping, Men, Lichuang, Chen, Zi, Niu, Qian, Wang, Hengbang, Lu, Ming, Yang, Dajun, Zhai, Yifan, Huang, Xiaojun
Publicado 2023

Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor‐naïve patients with myelofibrosis: Results of a phase II trial

por Zhang, Yi, Zhou, Hu, Jiang, Zhongxing, Wu, Dengshu, Zhuang, Junling, Li, Wei, Jiang, Qian, Wang, Xiuli, Huang, Jinwen, Zhu, Huanling, Yang, Linhua, Du, Xin, Li, Fei, Xia, Ruixiang, Zhang, Feng, Hu, Jianda, Li, Yan, Hu, Yu, Liu, Jing, Jin, Chenghao, Sun, Kai, Zhou, Zeping, Wu, Liqing, Yu, Wenjuan, Jin, Jie
Publicado 2022

S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS

por Zhang, Yi, Zhou, Hu, Zhuang, Junling, He, Aili, LI, Yarong, Yang, Linhua, Du, Xin, Gao, Sujun, He, Guangsheng, Hong, Mei, Jiang, Qian, Jiang, Zhongxing, Kai, Sun, Yue, Lingling, Zheng, Cuiping, Zhou, Zeping, Jin, Chenghao, Jing, Hongmei, Liu, Lin, Liu, Qingchi, Wang, Jishi, Wu, Wen, Xu, Yajing, Wu, Dengshu, Xu, Na, Zhang, Feng, Zhang, Jin, Zhu, Huanling, Xiao, Zhijian, Jin, Jie
Publicado 2023